NAD+observational2026

NAD+ capping of sibD transcripts in E. coli is mediated by its minimal promoter and enhanced by ppGpp.

Nucleic acids research

confidence

Key findings

NAD+ capping of sibD transcripts in E. coli mediated by its minimal promoter and enhanced by ppGpp; molecular biology study, no clinical/biological endpoints.

View source on PubMed (PMID 41732914) ↗

Sample size
not_reported
Population
Escherichia coli (in vitro)
Dosing
not_reported
Duration
not_reported
Route
not_reported
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

Recently, nicotinamide adenine dinucleotide (NAD+) and other nucleotide analogs have been identified as non-canonical RNA caps in both prokaryotes and eukaryotes. In Escherichia coli, NAD capping has been shown to be influenced by environmental conditions in a gene-specific manner, yet its regulatory mechanisms remain poorly understood. We previously reported that most transcripts produced by sibD are NAD-capped during the stationary phase. In this study, we found that the 35-bp minimal promoter of sibD is sufficient for its NAD capping. When this minimal promoter was applied to express genes not typically producing NAD-RNAs, their transcripts could also be NAD-capped. These findings strongly support that NAD capping in E. coli occurs during transcription initiation mediated by the promoter and RNA polymerase. Additionally, the bacterial alarmone ppGpp and the small protein DksA, both transcription initiation regulators, synergistically enhance transcription of both NAD-capped and uncapped RNAs from sibD and its homologous genes, sibC and sibE, in vitro. In contrast, the ppGpp⁰ mutant, deficient in ppGpp synthesis, showed a significant reduction in NAD-RNA production from these genes. Our findings elucidate the cis-elements and trans-acting factors mediating NAD capping during transcription initiation, offering novel insight into this regulatory process.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.